Canary Ambient™ enables actionable insights into patient-clinician dialogues, tracking speech patterns, and delivering real-time evaluations of cognitive and behavioral health conditions
PROVO, Utah, Oct. 16, 2024 /PRNewswire/ — Canary Speech, a leader in vocal biomarker technology, has announced today the launch of Canary Ambient™, an API-first solution designed for healthcare and contact centers, which offers a first-of-its-kind, real-time voice analysis during clinical conversations. Canary Ambient™ is a clinical decision support software enabling actionable insights into patient-clinician dialogues, tracking speech patterns, and real-time assessments of cognitive and behavioral health conditions.
With its advanced voice processing capabilities, Canary Ambient™ brings unobtrusive and impactful insights, helping organizations identify potential at-risk individuals who would benefit from further evaluation, improving overall communication and efficiency of patient care – all done while listening in the background.
“Canary Speech’s clinical ambient listening allows for seamless vocal biomarker analysis that captures the natural interaction between a clinician and their patient with no additional prompting required,” said Nate Blaylock, CTO of Canary Speech. “This technology supports the clinician in identifying patients who may benefit from additional screening.”
“We are thrilled to offer Canary Ambient, which will allow many more organizations to integrate vocal biomarker analysis into existing workflows, improving patient care and customer service,” said Henry O’Connell, CEO of Canary Speech.
Key Features of Canary Ambient™ include:
Canary Ambient™ is now available for healthcare organizations and contact centers looking to enhance their capabilities through voice-driven insights and improve the data-driven support and efficiency provided to clinicians in determining whether further assessment is necessary. For more information on Canary Ambient™, visit this page.
About Canary Speech
Canary Speech is the leading AI-powered voice biomarker health tech company that uses real-time patented vocal analysis to screen for mental health and neurological disorders. Canary’s vocal biomarker technology captures and analyzes speech data within seconds to identify irregularities in behavioral and cognitive changes before current clinical screening standards or noticeable symptoms for invisible illnesses like anxiety, depression and dementia. Canary Speech is a Utah-based company that advances speech and language applications for health systems, payers and pharmaceutical markets.
Press Contact:
Caitlyn Brooksby
caitlyn@canaryspeech.com
Disclaimer: This press release contains forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those anticipated due to various factors.
SOURCE Canary Speech
NEWTOWN, Pa., Dec. 22, 2024 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is…
Miami, Florida--(Newsfile Corp. - December 21, 2024) - Amid the vibrant backdrop of Art Basel…
Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…
MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…